Introduction: Monitoring and reporting of adverse drug reactions (ADRs) in specialized hospitals provide an important measure to identify and quantify the risks associated with the use of specific drugs.
INTRODUCTION
Detection of ADRs in hospitals could provide a mechanism for monitoring the safety of drug use in high-risk patient populations and stimulate the education of health professionals regarding potential ADR [1] . Studies have shown that between 10-20% of hospital inpatients experience an ADR during their hospitalization [2] [3] [4] [5] . The rate of reported ADRs in hospitalized patients differs from study to study. This is probably due to the differences in patients' demographics, the number of beds, medications on formulary, and the ADR definition used [6] .
Most of the studies have been conducted in general hospitals where patient populations and drug use patterns differ markedly from those of specialized ones. These differences impact on the frequency and nature of ADRs [7] . Detection of ADRs in a specialized hospital is essential to find more information regarding most commonly used drugs. This data is required to improve drug use patterns and drug management system in a hospital [8] . After the implementation of ADR reporting system in our hospital [9] , we educated health care professionals and involved clinical pharmacy students in ADR reporting. This study aimed to determine the pattern of hospital-acquired ADRs, in medical wards of a pulmonary teaching hospital. Another objective was to evaluate our system in quantity and quality of reported ADRs.
METHODS
The study was conducted on 11 wards (9 medical and 2 surgical) at Masih Daneshvari Hospital over a two year period from March 2009 to February 2011. Masih Daneshvari is tertiary care, multidisciplinary teaching hospital.
Clinicians and nurses were asked to inform pharmacovigilance department when they detect ADRs [9] . They were regularly reminded by an ADR bulletin [10] , training lectures and direct contacts. After the initial notification, the following information was documented in an ADR standard form: the patient's demographic details, a brief description of the ADR, previous allergies, co morbidities, the name of the suspected medication(s), the dose, the route of administration, the dates of starting and stopping therapy, reason for suspected drug(s) use, concomitant medication(s), management and outcome of the ADR.
As well as clinical pharmacist residents as part of their lung rotations training received a general idea of ADRs, ADR trigger medications, and the hospital's ADR reporting program. They collected ADR data by prospectively reviewing inpatient charts and patient interview. We also, set up designed boxes on each nursing station with the same color as ADR form (yellow) and some explanation on how, when, and why to report ADRs.
An ADR was defined according to the World Health Organization (WHO) definition as: "a response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis, or therapy of disease, or for the modification of physiological function."
Each ADR was classified according to the WHO system organ classification [11] . All reported ADRs were evaluated for the causality in accordance with Naranjo's algorithm [12] . The seriousness of reported adverse reactions was assessed based on the WHO definition, which included any adverse event that resulted in death, life-threatening situation, hospitalization, prolonged hospital stay, disability or birth defect. Assessment of preventability was determined using the scale developed by Schumock et al. [13] . (Appendix 1) ADR forms were then sent to the national ADR monitoring centre at the Ministry of Health for further evaluation.
RESULTS
During 2 years, a total of 11975 patients were admitted to the hospital, and 306 ADRs were reported from 272 patients. The ADR was the primary reason of hospitalization in 35 patients. At least one ADR was reported in 1.98% (95% confidence interval [CI]: 0.017-0.023) of patients during hospitalization and 0.30% (95%CI: 0.002-0.004) of admissions were caused by ADRs. In terms of the patient demographics in the reported ADRs, 3.1% (95%CI: 0.026-0.036) were women and 2.2% (95%CI: 0.019-0.025) were men. Incidence of ADRs in pediatric (0-18 years), adult (19-60 years) and geriatric (>60 years) groups was 1.2 (95%CI: 0.007-0.017), 3.1% (95%CI: 0.027-0.035) and 2.2% (95%CI: 0.017-0.027), respectively. The majority of the ADR reports was from the Department of Internal Medicine (32.03%), followed by the Coronary Care Unit (18.63%) as presented in Table 1 . The most frequent reports were due to anti-infective agents (34.08%), followed by central nervous system agents (12.69%) and antineoplastic agents (12.47%). The drug class involved in the ADRs is shown in Table 2 .
Rifampin was the most frequent anti-infective agent associated with the suspected ADRs such as nausea, vomiting, abdominal pain, urticaria, hepatic enzyme increased, pancytopenia, and stevens johnson syndrome ( Table 3 ). The gastrointestinal system was the most frequently affected system (21.90% of all reactions), followed by the skin and appendages system (18.98%). The classification of the ADRs by system-organ class is demonstrated in Table 4 . The causality assessment of ADRs revealed that 0.66% of the cases were detected as highly probable, 37.58% as probable and 61.76% as possible reactions. Seventy two (23.53%) of the ADRs were classified as serious according to the WHO definition and resulted in prolonged hospital stay, persistent disability or death. Table 5 shows the drugs in reports with a serious reaction.
Twenty-five (8.17%) of the ADRs were classified as preventable according to the scale developed by Schumock et al. [13] . Table 6 shows the drugs reported in a preventable reaction.
DISCUSSION
In March 2006, our hospital's pharmacovigilance unit was established to educate health care professionals regarding ADRs, promote the reporting of ADRs and monitor the safety of drug use in the patients [9] . The underreporting of ADRs was observed in our previous study. It was presumed that physicians and nurses' unawareness of ADR monitoring and reporting mechanism and the extensive workload of physicians and nurses could be two important reasons for under-reporting. We continued our educational program for health care professionals as lectures, morning report discussions, ADRs bulletin [10] , and added ADRs review to the daily responsibilities of clinical pharmacist residents. The number of ADRs reported to our unit was increased by 36.61% over the last two years that shows our programs could be useful to increase ADR reporting. Sullivan et al. showed that pharmacy student participation in the ADR reporting significantly increases the number of ADRs documented [6] . In other study, quality and quantity of spontaneous reporting ADRs were improved by economic incentives and educational activities [14] . [15] which is higher than our result. This variability could be explained by the different methods of detection of ADRs, as well as by the different wards where the patients are studied. It has been shown that the frequency of adverse drug events detected by spontaneous reporting is significantly lower than that assessed by patient monitoring. Besides higher frequencies of adverse drug events have been reported in studies performed on internal medicine wards or geriatric wards than in studies performed on general medicine wards [16] .
The value of our study is to identify the pattern of ADRs in a specialized hospital. The rate and pattern of ADRs vary among different hospitals because of differences in the local population characteristics and hospital major specialties [17] . In our study, the most frequent ADRs were related to antibiotics that are high consumption and great expenditure drugs in our hospital. While in other studies, different drug classes such as antineoplastic, cardiovascular, anticoagulant, nonsteroidal anti-inflammatory, hypoglycemic, and antiinfective agents have been most frequently associated with ADRs [8, [18] [19] [20] [21] [22] .
Review of ADRs reported with high usage items in a hospital is useful in the promotion of rational drug use [8] and planning of new studies to discover the problems. Our previous study has shown ceftriaxone as the most frequent anti-infective agent associated with the suspected ADRs [9] . But educating health care professionals about appropriate usage of ceftriaxone (indication, dosage, preparation, administration and patient care) changed drug utilization pattern and consequently ADR pattern. In present study, rifampin has been replaced as the most frequent antiinfective agent associated with the suspected ADRs. It could be rational because our hospital is a tuberculosis referral center and rifampin has a high usage. On the other hand, the rate of hepatotoxicity induced by anti-TB drugs is high in our hospital [23] . Several factors have been implicated in the development of hepatotoxicity because of anti-TB treatment. Drug formulation, undernutrition and plasma levels of anti-TB drugs [24] should be investigated as important factors in our patients.
Gastro-intestinal system was the organ system which was most commonly affected by ADRs. Skin and appendages systems have usually been reported as the most affected organ system by ADRs [9, 25, 26] . This reveals our educations have been successful to change the reporters' attentions to the patient's symptoms instead of the merely visible ADRs. Pathological and laboratory data which are objective markers of ADRs should be considered by more education [9] . In addition, the pattern of ADRs may be influenced by the profile of drug prescriptions and the wide use of anti-TB drugs may also partially explain why gastrointestinal system was the organ system most commonly affected.
In this study, 8.17% of ADRs were preventable. Higher rate of preventable ADRs in other studies (the wide range of 30-70%) [27, 28] and 14.13% reduction in preventable ADRs in our hospital (22.30% preventable ADRs in previous study) suggest that our education programs and preventive strategies have been effective. Serious ADRs have been increased from 16.70% (in previous study) to 23 .53% (in this study). Perhaps our strategy has been successful to detect serious ADRs more efficiently. The assessment of whether an ADR has increased the length of stay or caused persistent disability or death can be difficult because individual patient factors such as the nature and severity of the underlying disease, and social factors may also contribute to the length of stay [17] . We considered these factors and involved the clinical team for the assessments. We also sent a notice for health care professionals and warned mandatory reporting of serious ADRs according to the Ministry of Health regulations. Increased hepatic enzyme induced by rifampin was the most frequently reported serious ADR, as discussed above should be considered for more evaluations.
During the study, reported ADRs from our center to the national ADR monitoring centre at the Ministry of Health leaded to the batch recalls of two pharmaceutical products.
While ADRs reporting remains one of the most common methods of post-marketing drug safety surveillance, promoting ADR reporting improves postmarketing control on pharmaceutical products.
In conclusion, the pattern of ADRs in our hospital which is a specialized hospital with specific drug usage pattern is different from the studies conducted in other hospital settings. Dissemination of our experiences e.g. addition of ADRs review to the daily responsibilities of clinical pharmacist residents helps to improve the quality of patient care by ensuring safer use of drugs. We are planning to design a multicenter study to understand the ADRs pattern in our population.
